arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

SATURDAY 12 OCTOBER 2019

Saturday 12 Oct

Meet the expert sessions

08:00

M01 Hematology

Malgorzata Mikulska, FECMM, Italy & Alessandro Busca, Italy

08:00

M02 Peadiatrics

Simone Cesaro, Italy & Adillia Warris, FECMM, UK

08:00

M03 Candida in the ICU

Matteo Bassetti, Italy & Jean-François Timsit, France

08:00

M04 Diagnostics/Laboratory

Alida Talento, Ireland & Michaela Lackner, FECMM, Austria

08:00

M05 Tropical

Arunaloke Chakrabarti, FECMM, India & Rita Oladele, FECMM, Nigeria

08:45

Time to switch rooms

08:50

Plenary 2 - Highlights on fungal biology

08:50

PS 2.1 Candida

Christophe D'Enfert, France

09:20

PS 2.2 Aspergillus

Agostinho Carvalho, FECMM, Portugal

09:50

PS 2.3* Lineage-specific behavioural differences in isolates of Candida auris

Andrew Borman, United Kingdon

10:00

Coffee break

10:30

Plenary 3 - One World One Guideline ECMM MSG-ERC (EFISG) ISHAM Guidelines initiative

10:30

PS3.1 Mucormycosis

Oliver Cornely, FECMM, Germany

10:45

PS3.2 Endemic

George Thompson, USA

11:00

PS3.3 Rare moulds

Martin Hoenigl, FECMM, Austria

11:15

PS3.4 Rare yeasts

Sharon Chen, FECMM, Australia

11:30

Poster session 1

12:30

Lunch

12:30

Sponsored Integrated Symposium 2

More information on www.timm2019.org/sponsored-symposia

14:15

Parallel Symposia 5-9

Symposium 5 Lung transplantation

14:15

S05.1 Pre-transplant assessment

Blandine Rammaert, France

14:35

S05.2 Prophylaxis

John Perfect, USA

14:55

S05.3 Current guidelines

Shahid Husain, FECMM, Canada

15:15

S05.4 to be confirmed

15:25

S05.5* From the lung to the heart: fatal dissemination of azole-resistant Aspergillus fumigatus in a lung transplant patient

Rose-Anne Lavergne, France

Symposium 6 prophylaxis during hematology malignancies

14:15

S06.1 AML - in the era of FLT3 inhibitors

Russel Lewis, Italy

14:35

S06.2 ALL - there is a role for prophylaxis

Daniel Teschner, Germany

14:55

S06.3 Personalised medicine / approach by genetic risk factors

Pierre-Yves Bochud, Switzerland

15:15

S06.4 Baseline CT upon diagnosis of acute leukemia

Stefan Schwartz, Germany

15:35

S06.5* Investigating the impact of posaconazole prophylaxis on systematic fungal screening using galactomannan antigen, Aspergillus qPCR and Mucorales qPCR.

Anne-Pauline Bellanger, France

Symposium 7 Paediatric Mycology (EPMyN)

14:15

S07.1 Fluconazole and micafungin dosing in neonates

Roger Brüggemann, the Netherlands

14:35

S07.2 Antifungal susceptibility of paediatric candidemia

Zoi-Dorothea Pana, Greece

14:55

S07.3 Primary immunodeficiencies characterised by fungal infections

Fanny Lanternier, FECMM, France

15:15

S07.4 to be confirmed

15:25

S07.5* Isavuconazole use in pediatric hematoncologic patients: the Italian Association of Pediatric Hematology Oncology (AIEOP) experience

Nunzia Decembrino, Italy

Symposium 8 Immunologic Markers for Diagnosis and Treatment Stratification in Invasive Mold Infection

14:15

S08.1 Anti-mold immune response: the impact of  the host, the pathogen and translational implications

Agostinho Carvalho, FECMM, Portugal

14:35

S08.2 Immunologic markers for diagnosis of invasive aspergillosis and other invasive mold infections

Carol Garcia-Vidal, Spain

14:55

S08.3 Immunologic markers for treatment stratification in invasive mold infection

Philipp Köhler, FECMM, Germany

15:15

S08.4 Fungal Translocation: from persistent inflammation to non-AIDS events

Martin Hoenigl, FECMM, Austria

15:35

S08.5* Immunological characteristics of Broncho alveolar lavage in neutropenic patients with invasive aspergillosis

Claire Aguilar, France

Symposium 9 Chronic Pulmonary Aspergillosis

14:15

S09.1 The global burden of chronic pulmonary aspergillosis

14:35

S09.2 Diagnosis of CPA. Where do we stand?

Aleksandra Barac, FECMM, Serbia

14:55

S09.3 Current treatment options for CPA

15:15

S09.4 Future directions

David Denning, FECMM, United Kingdom

15:25

S09.5* Raised amphotericin B MIC in Aspergillus fumigatus isolates from patients with Chronic Pulmonary Aspergillosis

Fiona Lynch, United Kingdom

15:45

Coffee break

16:15

Parallel Symposia 10-14

Symposium 10 Symposium Sensing the host

16:15

S10.1 Phosphate acquisition and virulence in human fungal pathogens

16:35

S10.2 Hybrid histidine kinases: major sensing proteins in pathogenic fungi

Nicolas Papon, France

16:55

S10.3 Adapting to the host: how Candida causes bloodstream infection

Oliver Kurzai, Germany

17:15

S10.4* to be confirmed

17:25

S10.5* to be confirmed

Xinyue Chen, Japan

17:35

S10.6* to be confirmed

Symposium 11 The anti-fungal pipeline

16:15

S11.1 Olorofim - a novel mould-active antifungal (F2G

John Rex, FECMM, UK

16:40

S11.2 Fosmanogepix: a novel, broad spectrum antifungal therapy in clinical development, Amplyx

Michael Hodges, USA

17:05

S11.3 tba Scynexis

tba

Symposium 12 Environment & fungal outbreaks

16:15

S12.1 Frogs

Matthew Fisher, United Kingdom

16:35

S12.2 Cryptococcus gattii

Ferry Hagen, FECMM, the Netherlands

16:55

S12.3 Natural disasters

Tom Chiller, US

17:15

S12.4 Genomic sequencing

Marie Desnos, France

17:35

S12.5* Outbreak of fluconazole-resistant Candida parapsilosis in a hospital ward: arguments for clonal transmission and environmental persistence

Arnaud Fekkar, France

Symposium 13 Fungal respiratory infections in cystic fibrosis (the ECMM/ISHAM working Group Fri-CF)

16:15

S13.1 Rasamsonia species and other emerging fungi in CF

Solène Le Gal, France

16:35

S13.2 Immunodiagnosis of Scedosporium/Lomentospora infection - lessons from immunoproteomic studies

Andoni Ramirez-Garcia, Spain

16:55

S13.3 Bacterial / Fungal interactions in the CF mucus

Françoise Botterel, France

17:15

S13.4* Morphology, growth and biofilm formation of the black yeast-like fungus Exophiala dermatitidis is influenced by Pseudomonas aeruginosa under in vitro cystic fibrosis conditions.

Lisa Kirchhoff, Germany

17:25

S13.5 to be confirmed

17:35

S13.6* Study of antigenic markers for serological detection of Scedosporium spp. in Cystic Fibrosis patients

Leire Martin-Souto, Spain

Symposium 14 Teaching Medical Mycology: what, how, to whom and when

16:15

S14.1 Mycology teaching in Medical School - How much, what to choose, at what level

Peter Rath, FECMM, Germany

16:35

S14.2 Mycology teaching in Medical School  - Is student demography  important to what should be taught

Ester Segal, FECMM, Israel

16:55

S14.3 Specific courses outside the European Continent – The Indian Example

Ruth Ashbee, United Kingdom

17:15

S14.4 Teaching Clinical Laboratory Mycology–How and who is the audience

Sevtap Arikan-Akdagli, FECMM, Turkey

17:35

S14.5 The African example

Aude Sturny, France

18:00

Sponsored Integrated Symposium 3

More information on www.timm2019.org/sponsored-symposia

19:30

Sponsored reception